RT Journal Article
SR Electronic
T1 Predicting the Epidemic Curve of the Coronavirus (SARS-CoV-2) Disease (COVID-19) Using Artificial Intelligence
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.17.20069666
DO 10.1101/2020.04.17.20069666
A1 Kolozsvári, László Róbert
A1 Bérczes, Tamás
A1 Hajdu, András
A1 Gesztelyi, Rudolf
A1 Tiba, Attila
A1 Varga, Imre
A1 Al-Tammemi, Ala’a B.
A1 Szőllősi, Gergő József
A1 Harsányi, Szilvia
A1 Garbóczy, Szabolcs
A1 Zsuga, Judit
YR 2021
UL http://medrxiv.org/content/early/2021/01/27/2020.04.17.20069666.abstract
AB The aim of our study was to predict the epidemic curves (daily new cases) of COVID-19 pandemic using Artificial Intelligence (AI)-based Recurrent Neural Networks (RNNs), then to compare and validate the predicted models with the observed data. We used the publicly available datasets from the World Health Organization and Johns Hopkins University to create a training dataset, then we used RNNs with gated recurring units (Long Short-Term Memory) to create two prediction models. Information collected in the first t time-steps were aggregated with a fully connected (dense) neural network layer and a consequent regression output layer to determine the next predicted value. We also used Root Mean Squared Logarithmic Errors (RMSLE) to compare the predicted models with the observed data. The result of our study underscores that the COVID-19 pandemic is a propagated source epidemic, therefore repeated peaks on the epidemic curve are to be anticipated. Besides, the errors between the predicted and validated data and trends seems to be low. The influence of this pandemic is significant worldwide and has already impacted our daily life. Decision makers must be aware, that even if strict public health measures are executed and sustained, future peaks of infections are possible.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: This study was supported by the European Union, co-financed by the European Social Fund and European Regional Development Fund [Grant No. EFOP-3.6.1-16-2016-00022 Debrecen Venture Catapult Program (providing support for SH, LRK), by the European Union [EFOP-3.6.2-16-2017-00009 Establishing Thematic Scientific and Cooperation Network for Clinical Research (providing support for RG), by the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences (providing support for JZ), by the Hungarian Brain Research Program 2.0 under grant number 2017-1.2.1-NKP-2017-00002 and the ED_18-1-2019-0028 providing support for (LRK, TB, AT). The research was also supported by the UNKP-19-3-I. New National Excellence Program of the Ministry for Innovation and Technology (AT). The research was supported in part by the project EFOP-3.6.2-16-2017-00015 supported by the European Union, co-financed by the European Social Fund. This work was also supported in part by the project EFOP-3.6.3-VEKOP-16-2017-00002, sup-ported by the European Union, co-financed by the European Social Fund (IV). The funders had no role in the writing of the manuscript or the decision to submit it for publication, no involvement in data collection, analysis, or interpretation; trial design; patient recruitment; or any aspect pertinent to the study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data sources are publicly available and described in the methods section.